Tirzepatide for Thyroid: What the Evidence Shows
What human and animal studies show about Tirzepatide for thyroid, how strong that evidence is, and what is still unproven.
- Strongest evidence
- None graded
- no study with an outcome for thyroid (PubMed search, 2 Oct 2026)
- Human studies
- None found
- with an outcome for thyroid, in our evidence file (PubMed search, 2 Oct 2026)
- Animal studies
- None found
- with an outcome for thyroid, in our evidence file (PubMed search, 2 Oct 2026)
Evidence for thyroid
None of the study abstracts we summarised for Tirzepatide reported an outcome for thyroid (PubMed search, 2 Oct 2026). Claims that it helps with thyroid are unproven.
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Thyroid: the boxed warning is the main fact
MedlinePlus says your thyroid is a small, butterfly-shaped gland at the front of your neck that makes hormones controlling how the body uses energy.[16]
Zepbound's boxed warning says tirzepatide causes thyroid C-cell tumours in rats and that it is unknown whether it causes them, including medullary thyroid carcinoma, in humans.[17]
The label contraindicates it in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.[17]
It tells prescribers to counsel patients on symptoms of thyroid tumours such as a neck mass, trouble swallowing or breathing, or persistent hoarseness.[17]
What it does and does not say about underactive or overactive thyroid
The label says routine calcitonin monitoring or thyroid ultrasound is of uncertain value for early detection of MTC.[17]
A pharmacovigilance study of ear, nose and throat effects found medullary and papillary thyroid carcinoma had the highest signals for GLP-1 drugs in a reporting database, which shows reporting patterns and not risk.[18]
No trial tested tirzepatide for thyroid disease; an observational review found no clear increase in thyroid disorders among GLP-1 drug users.[19]
Other peptides people research for thyroid
No other peptide in our index has a thyroid page yet.
All peptides for thyroid, comparedCommon questions
Does Tirzepatide help with thyroid?
None of the studies we summarised for Tirzepatide (PubMed search, 2 Oct 2026) measured an outcome for thyroid. Treat claims that it helps with thyroid as unproven.
Is Tirzepatide approved for thyroid?
Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for thyroid?
There is no single answer. Our thyroid overview compares each candidate by evidence grade and legal status rather than by popularity.
Does tirzepatide cause thyroid cancer?
In rats it causes thyroid C-cell tumours. The label says it is unknown whether it does in humans, and it is contraindicated with a personal or family history of medullary thyroid carcinoma.[17]
Can you take tirzepatide with hypothyroidism?
The cached label does not list hypothyroidism as a contraindication; the contraindications are medullary thyroid carcinoma history, MEN type 2 and serious hypersensitivity.[17]
Does tirzepatide affect thyroid function?
An observational review found no clear increase in thyroid disorders among GLP-1 drug users, but it did not examine tirzepatide separately.[19]
More on Tirzepatide
Sources
- 1PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 2PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 15PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 16Official web pageOfficial web page · web page
- 17ZEPBOUND prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 18Otolaryngologic Side Effects of GLP-1 Receptor Agonists.The Laryngoscope · 2025PMID 39936458Accessed 2 Oct 2026
- 19Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies.Diabetes, obesity & metabolism · 2025PMID 40196933Accessed 2 Oct 2026
Found an error? Report a correction.